D-149-2013 Class II Terminated
FDA drug recall D-149-2013 was initiated by West-Ward Pharmaceutical Corp. on Dec 5, 2012 and is designated Class II. Reason for recall: Presence of Foreign Substance: Tablets are being recalled due to gray defects identified in the tablets. The recall status is terminated (terminated Mar 18, 2015). Affected quantity: 128,319 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 13, 2013
- Initiation Date
- Dec 5, 2012
- Termination Date
- Mar 18, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 128,319 bottles
Product description
PredniSONE Tablets, USP, 10 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1473-01), b) 1000-count tablets per bottle (NDC 0143-1473-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.
Reason for recall
Presence of Foreign Substance: Tablets are being recalled due to gray defects identified in the tablets.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: 69403A, 69403B, Exp 10/15; 69404A, 69405A, 69515A, 69702A, 69702B, 69703A, Exp 11/15; 69767A, 69767B, Exp 12/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-149-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026